home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Software Vault: The Diamond Collection
/
The Diamond Collection (Software Vault)(Digital Impact).ISO
/
cdr16
/
med9505d.zip
/
M9550805.TXT
< prev
next >
Wrap
Text File
|
1995-03-25
|
2KB
|
34 lines
Document 0805
DOCN M9550805
TI Inactivation and elimination of viruses during preparation of human
intravenous immunoglobulin.
DT 9505
AU Uemura Y; Yang YH; Heldebrant CM; Takechi K; Yokoyama K; Alpha
Therapeutic Corporation, Los Angeles, CA 90032.
SO Vox Sang. 1994;67(3):246-54. Unique Identifier : AIDSLINE MED/95167802
AB We report here the results of our evaluation of virus inactivation
during the manufacturing steps of two intravenous immunoglobulin (IGIV)
preparations. Virus inactivation and/or removal by processing steps,
such as ethanol fractionation and polyethylene glycol precipitation, and
deliberate virucidal steps, such as solvent/detergent treatment and
pasteurization, were tested on a variety of human pathogenic and
experimental model viruses, including human immunodeficiency, Hepatitis
C, Mumps, Vaccinia, Chikungunya, Vesicular Stomatitis, Sindbis, and ECHO
viruses. All viruses were successfully inactivated and/or eliminated by
the processing steps studied. In some cases, however, multiple steps
were required. We conclude that the incorporation of steps deliberately
designed to inactivate or remove viruses during the production of IGIV
provides an extra measure of viral safety.
DE Alcohol, Ethyl/PHARMACOLOGY Alphavirus/DRUG EFFECTS
Detergents/PHARMACOLOGY Echoviruses/DRUG EFFECTS Evaluation Studies
Fractionation Heat Hepatitis C Viruses/DRUG EFFECTS Human HIV-1/DRUG
EFFECTS HIV-2/DRUG EFFECTS Immunoglobulins, Intravenous/*ISOLATION &
PURIF Mumps Virus/DRUG EFFECTS Paramyxovirus/DRUG EFFECTS
Plasma/*VIROLOGY Polyethylene Glycols/PHARMACOLOGY Precipitation
Safety Solvents/PHARMACOLOGY Virus Diseases/*PREVENTION &
CONTROL/TRANSMISSION *Viruses/DRUG EFFECTS/PHYSIOLOGY JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).